Home » Topics » Regulatory » Patents

Patents
RSS

Taisho reports 5-HT4 agonists for GI disorders

April 19, 1996

Byk Gulden researches anti-Helicobacter agents

April 19, 1996

More antiplatelet agents from Thomae

April 19, 1996

Antiplatelet agents emerging from the Thomae pipeline

April 19, 1996

New series of thrombin inhibitors claimed by Thomae

April 19, 1996

SKB discloses NK3 antagonists in patent literature

April 19, 1996

Nikken Chemicals describes antiallergy agents

April 19, 1996

Abbott claims new 5-LO inhibitors

April 19, 1996

Two novel series of LTB4 antagonists from Boehringer Ingelheim

April 19, 1996

Leukotriene D4 antagonists reported by Leo Denmark

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...